Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Implementing technology-based embedded assessment in the home and community life of individuals aging with disabilities: a participatory research and development study.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Neuromyelitis optica spectrum disorders with multiple brainstem manifestations: a case report.
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
Analysis of neuromuscular parameters in patients with multiple sclerosis and gait disorders.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection.
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Incorporating covariates in skewed functional data models.
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
Systematic review versus internet search: considerations about availability and reliability of medical information regarding pregnancy in women with multiple sclerosis.

Pages